Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Praet · SciRah

Researcher profile · Semantic Scholar

M. Praet

Share profile

M. Praet — researcher profile on SciRah

h-index: 13
Works: 27
Citations: 2,623

Most-cited papers

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
B. Nordlinger, H. Sørbye, B. Glimelius, G. Poston +15 more
2008The Lancet1,869 citations Open access
Semantic Scholar
Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study.
J. Van Laethem, P. Hammel, F. Mornex, D. Azria +11 more
2010Journal of Clinical Oncology254 citations Open access
Semantic Scholar
Adjuvant ganglioside GM2-KLH/QS-21 vaccination versus observation after resection of primary tumor > 1.5 mm in patients with stage II melanoma: results of the EORTC 18961 randomized phase III trial.
A. Eggermont, S. Suciu, P. Rutkowski, J. Marsden +13 more
2013Journal of Clinical Oncology91 citations
Semantic Scholar
Weekly infusional high-dose fluorouracil (HD-FU), HD-FU plus folinic acid (HD-FU/FA), or HD-FU/FA plus biweekly cisplatin in advanced gastric cancer: randomized phase II trial 40953 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group and the Arbeitsgemeinschaft I
Manfred P. Lutz, H. Wilke, D. J. Theo Wagener, U. Vanhoefer +10 more
2007Journal of Clinical Oncology73 citations
Semantic Scholar
Feasibility and risks of pre-operative chemotherapy (CT) with Folfox 4 and surgery for resectable colorectal cancer liver metastases (LM). Interim results of the EORTC Intergroup randomized phase III study 40983
B. Nordlinger, H. Sørbye, M. Debois, M. Praet +6 more
200556 citations
Semantic Scholar
Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma: randomized phase II study 40984 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group.
M. Lutz, E. Van Cutsem, T. Wagener, J. Van Laethem +16 more
2005Journal of Clinical Oncology54 citations
Semantic Scholar
Raltitrexed (Tomudex) versus standard leucovorin-modulated bolus 5-fluorouracil: Results from the randomised phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1).
I. Popov, A. Carrato, A. Sobrero, M. Vincent +12 more
2008European Journal of Cancer52 citations
Semantic Scholar
In-vivo and in-vitro mitochondrial membrane damages induced in mice by adriamycin and derivatives.
M. Praet, J. Ruysschaert
1993Biochimica et Biophysica Acta36 citations
Semantic Scholar
In vivo and in vitro modifications of the mitochondrial membrane induced by 4' Epi-adriamycin.
M. Praet, M. Laghmiche, G. Pollakis, Erik Goormaghtigh +1 more
1986Biochemical Pharmacology27 citations
Semantic Scholar
A new class of free radical scavengers reducing adriamycin mitochondrial toxicity.
M. Praet, P. Calderon, Georgios Pollakis, M. Roberfroid +1 more
1988Biochemical Pharmacology26 citations
Semantic Scholar
Comparison of adriamycin and derivatives uptake into large unilamellar lipid vesicles in response to a membrane potential.
M. Praet, F. Defrise-Quertain, J. Ruysschaert
1993Biochimica et Biophysica Acta15 citations
Semantic Scholar
O-0028 Adjuvant Folfox4 +/- Cetuximab in KRAS Wild-Type Patients with Resected Stage III Colon Cancer Results from the Petacc8 Intergroup Trial
J. Taieb, J. Tabernero, E. Mini, F. Subtil +16 more
201213 citations Open access
Semantic Scholar
Adjuvant chemotherapy alone versus chemoradiation after curative resection for pancreatic cancer : feasibility results of a randomised EORTC/FFCD/GERCOR phase II/III study (40013/22012/0304)
J. Van Laethem, E. Van Cutsem, P. Hammel, F. Mornex +6 more
200813 citations
Semantic Scholar
Increasing therapeutic effect and reducing toxicity of doxorubicin by N-acyl dehydroalanines.
Pedro M. Buc-Calderon, M. Praet, J. Ruysschaert, M. Roberfroid
1989European Journal of Cancer and Clinical Oncology12 citations
Semantic Scholar
Free radical modulation by N-substituted dehydroalanines, a new way to improve therapeutic activity of anticancer drugs.
Pedro M. Buc-Calderon, M. Praet, J. Ruysschaert, M. Roberfroid
1987Cancer Treatment Reviews11 citations
Semantic Scholar
Captopril: a protective agent in renal warm ischemia in rats.
W. Oosterlinck, R. Roelandt, W. D. De Sy, M. Praet
1985European Urology9 citations
Semantic Scholar
Lapatinib in combination with ECF/x in EGFR1 or HER2-overexpressing first-line metastatic gastric cancer (GC): A phase II randomized placebo controlled trial (EORTC 40071).
A. Roth, M. Moehler, M. Mauer, A. Schad +5 more
20108 citations
Semantic Scholar
Detection of lytic antimycobacterial antibodies by immune lysis of liposomes sensitized to tuberculin.
Franz Legros, Manuel Castillo, M. Praet, M. Vandenbranden +7 more
1988JIM - Journal of Immunological Methods3 citations
Semantic Scholar
Survival after peri-operative chemotherapy with folfox 4 and surgery for resectable colorectal cancer liver metastases. Final results of the eortc intergroup randomized phase III study 40983
B. Nordlinger, H. Sørbye, L. Collette, M. Praet +12 more
20072 citations
Semantic Scholar
Reduction of toxicity and increase of antitumor effect of adriamycin by N-acyl dehydroalanines, a new family of free radical scavengers.
Pedro M. Buc-Calderon, M. Praet, J. Ruysschaert, M. Roberfroid
1990Advances in Experimental Medicine and Biology2 citations
Semantic Scholar
Final results of the PETACC-1 trial of bolus 5-FU/LV vs raltitrexed: An unsuccessful story?
I. Popov, J. Wils, A. Carrato, A. Sobrero +6 more
20081 citations
Semantic Scholar
Cultural Diversity and Political Unity in the Innovation Ecosystem
M. Praet, Tristan du Puy
20160 citations
Semantic Scholar
Long term survival data from EORTC study 40983 : Perioperative chemotherapy for resectable liver metastases from colorectal cancer
B. Nordlinger, H. Sørbye, B. Glimelius, G. Poston +15 more
20120 citations Open access
Semantic Scholar
Lapatinib in combination with ECF/x in EGFR1 positive first-line metastatic gastric cancer (GC): A phase II randomized placebo controlled trial (EORTC 40071).
M. Moehler, A. Schad, M. Mauer, M. Praet +4 more
20120 citations
Semantic Scholar
EIROFORUM: Building the European Research Area
M. Praet, F. Mazurelle
20010 citations
Semantic Scholar
Mitochondrial toxicity of 4' epi-adriamycin (4'Epi-ADM) in vivo and in vitro
M. Praet, M. Laghmiche, G. Pollakis
19860 citations
Semantic Scholar
Free radicals formation and membrane damages induced by adriamycin in mitochondria: A study in vivo and in vitro
E. Goormaghtigh, G. Pollakis, M. Praet, M. Delmelle +2 more
19840 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Ruysschaert×9
Invite
J. Ruysschaert — researcher profile on SciRah
E. Van Cutsem×7
Invite
E. Van Cutsem — researcher profile on SciRah
B. Nordlinger×6
Invite
B. Nordlinger — researcher profile on SciRah
L. Collette×6
Invite
L. Collette — researcher profile on SciRah

×4

Invite

H. Sørbye — researcher profile on SciRah

B. Glimelius×4

Invite

B. Glimelius — researcher profile on SciRah

Invite

G. Poston — researcher profile on SciRah

Invite

P. Schlag — researcher profile on SciRah

W. Bechstein×4

Invite

W. Bechstein — researcher profile on SciRah

Invite

E. Walpole — researcher profile on SciRah

J. Van Laethem×4

Invite

J. Van Laethem — researcher profile on SciRah

Invite

M. Mauer — researcher profile on SciRah